Index
Module 6 • Infectious Diseases
Infectious Diseases I
52%
Data Tables
Infectious Diseases I
Jacob Schwarz ~2 min read Module 6 of 20
32
/ 61

Infectious Diseases I

Clinical

Definition

ACG 2013

IDSA/SHEA 2018

IDSA/SHEA

2021 Focused Update

ACG 2021

First

recurrence

Same regimen

as used for

initial episode,

unless severe;

if severe,

vancomycin

should be used

Vancomycin 125

mg 4 times daily

for 10 days if

metronidazole was

used for initial

episode

β€”ORβ€”

Prolonged tapered

and pulsed

vancomycin

regimen if standard

regimen was used

for initial episode;

for example: 125

mg 4 times daily for

10–14 days, BID for

1 wk, once daily for

1 wk, then every 2

or 3 days for 2–8 wk

β€”ORβ€”

Fidaxomicin

200 mg PO/NG/

FT BID for 10 days

if vancomycin was

used for initial

episode

Fidaxomicin 200 mg PO/

NG/FT BID for 10 daysβ€”

ORβ€”BID for 5 days, then

once every other day for

20 days

Alternative: Vancomycin

PO in tapered and pulsed

regimen

β€”ORβ€”

Vancomycin 125 mg

given 4 times daily PO for

10 days

Adjunctive therapy:

Bezlotoxumab 10 mg/

kg IV once during

administration of above

antibiotics

Recommend

fidaxomicin for first

recurrence after initial

course of vancomycin

or metronidazole

(conditional

recommendation,

moderate-quality

evidence)

Suggest tapering/pulsed

dose vancomycin first

recurrence after initial

course of fidaxomicin,

vancomycin, or

metronidazole (strong

recommendation, very

low-quality evidence)

Suggest bezlotoxumab

for high risk of

recurrence (conditional

recommendation,

moderate-quality

evidence)

Table 3. Treatment Options for Clostridioides difficile Infection (continued)
HD Video Explanation β€” Synchronized with PDF
Starts at: minute 31 Open on YouTube